MED - Medifast, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.17B
Enterprise Value 31.03B
Trailing P/E 15.82
Forward P/E 113.59
PEG Ratio (5 yr expected) 10.65
Price/Sales (ttm)1.61
Price/Book (mrq)10.53
Enterprise Value/Revenue 31.42
Enterprise Value/EBITDA 610.89

Trading Information

Stock Price History

Beta (5Y Monthly) 1.15
52-Week Change 3-28.23%
S&P500 52-Week Change 37.50%
52 Week High 3142.97
52 Week Low 349.03
50-Day Moving Average 378.58
200-Day Moving Average 387.08

Share Statistics

Avg Vol (3 month) 3321.13k
Avg Vol (10 day) 3222.57k
Shares Outstanding 511.78M
Float 9.18M
% Held by Insiders 14.65%
% Held by Institutions 1115.36%
Shares Short (Apr. 29, 2020) 43.32M
Short Ratio (Apr. 29, 2020) 413.33
Short % of Float (Apr. 29, 2020) 440.72%
Short % of Shares Outstanding (Apr. 29, 2020) 428.17%
Shares Short (prior month Mar. 30, 2020) 43.32M

Dividends & Splits

Forward Annual Dividend Rate 44.52
Forward Annual Dividend Yield 44.94%
Trailing Annual Dividend Rate 33.76
Trailing Annual Dividend Yield 33.95%
5 Year Average Dividend Yield 4N/A
Payout Ratio 459.78%
Dividend Date 3May 05, 2020
Ex-Dividend Date 4Mar. 29, 2020
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Mar. 30, 2020

Profitability

Profit Margin 10.41%
Operating Margin (ttm)12.37%

Management Effectiveness

Return on Assets (ttm)27.25%
Return on Equity (ttm)64.98%

Income Statement

Revenue (ttm)726.26M
Revenue Per Share (ttm)61.84
Quarterly Revenue Growth (yoy)7.60%
Gross Profit (ttm)536.86M
EBITDA 94.54M
Net Income Avi to Common (ttm)75.64M
Diluted EPS (ttm)6.29
Quarterly Earnings Growth (yoy)-11.00%

Balance Sheet

Total Cash (mrq)105.26M
Total Cash Per Share (mrq)8.97
Total Debt (mrq)12.81M
Total Debt/Equity (mrq)11.56
Current Ratio (mrq)1.97
Book Value Per Share (mrq)9.44

Cash Flow Statement

Operating Cash Flow (ttm)78.26M
Levered Free Cash Flow (ttm)56.5M